Connect with us

Business

Pfizer Says FDA Will Soon Authorize COVID-19 Vaccine For 12-15 Age Group – NPR

The company said in late March that clinical trials showed the vaccine elicits “100% efficacy and robust antibody responses” in adolescents.

Published

on

Article feature image
ADVERTISEMENT

Syringes filled with the Pfizer-BioNTech COVID-19 vaccine are shown in April at the Christine E. Lynn Rehabilitation Center in Miami.
Wilfredo Lee/AP
The U.S. Food and Drug Administration is expected to authorize the Pfizer-BioNTech COVID-19 vaccine for children 12 to 15 years old, a decision that could come by some time early next week. The vaccine is currently authorized only for people age 16 and older.
A ruling should come “shortly,” Pfizer Chairman and CEO Albert Bourla told investors in a…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Ethereum is over $4,000—here’s how much money you’d have if you invested $1,000 at the beginning of 2021 – CNBC
Article feature image
Novavax Covid-19 Vaccine Faces Delay – The Wall Street Journal
Article feature image
The cybersecurity ‘pandemic’ that led to the Colonial Pipeline disaster – The Verge